Category: Intellectual property
-
University Develops, Patents New Coke Fuel Process
Researchers at Purdue University’s Calumet campus in Hammond, Indiana created a new less-expensive process for producing coke, a derivative of coal used in the making of steel, and received a U.S. patent for their discovery. Patent number 8,287,696 was awarded by the U.S. Patent and Trademark Office in October to Purdue-Calumet physics professor Robert Kramer…
-
University, Company Share Ion Detection Technology Patent
University of Texas at Arlington and Dionex Corporation in Sunnyvale, California recently received a patent for a new process that detects the charge of ions in a solution, and can enable more sensitive testing for compounds in water, food, and chemicals. Patent 8,293,099 from the U.S. Patent and Trademark Office was awarded in late October…
-
Synthetic Sugars Developer Lands $3.5M Venture Financing
Proterro Inc. in Ewing, New Jersey, a developer of synthetic sucrose for biofuels and chemicals, secured $3.5 million in new venture financing. The company also says the U.S. Patent and Trademark Office (USPTO) issued a notice of allowance for the genetically engineered bacteria used in its production process. The company combines genetic engineering with chemical…
-
Wake Forest Health Expands Commercialization Program
Wake Forest Baptist Medical Center in Winston-Salem, North Carolina started a new division to encourage development of new products and services from its research. Wake Forest Innovations, as the division is called, is expected to generate new revenue streams for the medical center by growing and managing new business partnerships. Wake Forest Innovations has a…
-
EU Approves Unitary Patent Regulations
The European Parliament in Strasbourg, France approved draft regulations establishing a common patent system for 25 participating member counties of the European Union. The approved regulations create a unitary patent instrument and govern the language versions of the patent documents. However, EU members Italy and Spain are not taking part in the program. The unitary…
-
MD Anderson, GlaxoSmithKline Partner on Cancer Immunotherapy
MD Anderson Cancer Center in Houston, part of the University of Texas, and the global pharmaceutical company GlaxoSmithKline will jointly conduct research leading to new therapeutic antibodies that help the immune system fight cancer. The agreement over its full lifetime could earn MD Anderson as much as $335 million. The agreement gives GlaxoSmithKline exclusive worldwide…
-
Supreme Court to Take Gene Patents Case
The New York Times reports today the U.S. Supreme Court will hear a case about the ability of inventors to patent human genes. The case involves patent claims by Myriad Genetics, a developer of molecular diagnostics in Salt Lake City, that is being challenged by a group of physicians, scientists, and professional organizations. The suit…
-
Director David Kappos to Leave USPTO
The director of the U.S. Patent and Trademark Office David Kappos announced in an e-mail yesterday to USPTO staff that he plans to leave the agency by the end of January 2013. The news was reported late yesterday by the industry blog, IP Watchdog and confirmed independently by sources at USPTO. Kappos became USPTO director…
-
U.S. Patent Awarded for Protein Therapy Delivery Technology
Medgenics Inc., a biotechnology company in Misgav, Israel and San Francisco, received a U.S. patent for its technology for the sustained delivery of therapeutic proteins to treat anemia. Patent number 8,293,463 was awarded by the U.S. Patent and Trademark Office on 23 October 2012 to 11 inventors, including Andrew Pearlman, president of Medgenics Inc., and…
-
Special: Patent Office Director — Software Patents Working
U.S. Patent and Trademark Office (USPTO) director David Kappos pushed back at complaints about software patents harming American innovation, saying the current patent system has generated “an explosion of innovation.” Kappos discussed software patents today in a speech to the progressive think tank Center for American Progress in Washington, D.C. Kappos answered charges that the…